Company snapshot
Market Cap
$41B
Large-cap2016 — today
10-Year Price
+228%
2016 — today
52-Week Range
$110.24$159.00
Current $144.78· 71%
Featured in rankings
S&P500Most Undervalued Healthcare StocksBest Healthcare Dividend StocksMost Undervalued Value StocksMost Undervalued Dividend StocksMost Undervalued Growth StocksCheapest Large-Cap Stocks
Rankings recomputed after each US market close — see where A stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ONCBeOne Medicines Ltd. | 4.9 | — |
| IDXXIDEXX Laboratories, Inc. | 36.5 | — |
| TEVATeva Pharmaceutical Industries Limited | 61.4 | — |
| RVMDRevolution Medicines, Inc. | -23.4 | — |
| ALNYAlnylam Pharmaceuticals, Inc. | 43.6 | — |
| NTRANatera, Inc. | -242.9 | — |
| HUMHumana Inc. | 37.9 | 0.9% |
| BDXBecton, Dickinson and Company | 54.2 | 2.2% |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
28.5
Historically cheap
Historically cheap relative to the last 10 years
Sector median 25.0above sector
P/B ratio
5.6
Around average
Around the 10-year average
Sector median 2.5above sector
EV / EBITDA
22.2
Above average
Pricier than usual over the last 10 years
Sector median 15.3above sector
Dividend Yield
0.5%
Near historic low
Near historic low — last 10 years
Sector median 1.9%below sector
PEG ratio
2.9
Historically pricey
Historically pricey — last 10 years
Sector median 1.4above sector
FCF Yield
3.7%
Above average
Above the 10-year average
Sector median -9.6%above sector